Prediction model for hepatocellular carcinoma occurrence in patients with hepatitis C in the era of direct‐acting anti‐virals

抄録

<jats:title>Summary</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Several factors associated with hepatocellular carcinoma (HCC) occurrence after sustained virological response (SVR) in patients with hepatitis C have been reported. However, few validation studies have been performed in the era of direct‐acting anti‐virals (DAAs).</jats:p></jats:sec><jats:sec><jats:title>Aims</jats:title><jats:p>To develop a prediction model for HCC occurrence after DAA‐mediated SVR and validate its usefulness.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We analysed 2209 patients with SVR and without a history of HCC who initiated DAA treatment at 24 Japanese hospitals. These patients were divided into a training set (1473 patients) and a validation set (736 patients).</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>In the training set, multivariate Cox proportional hazards analysis showed that the baseline BMI (≥25.0 kg/m<jats:sup>2</jats:sup>, <jats:italic>P</jats:italic> = 0.024), baseline fibrosis‐4 (FIB‐4) index (≥3.25, <jats:italic>P</jats:italic> = 0.001), albumin level at SVR (<4.0 g/dL, <jats:italic>P</jats:italic> = 0.010) and alpha‐foetoprotein level at SVR (≥5.0 ng/mL, <jats:italic>P</jats:italic> = 0.006) were significantly associated with HCC occurrence. We constructed a prediction model for HCC occurrence with these four factors (2 points were added for the FIB‐4 index, and 1 point was added for each of the other three factors). Receiver operating characteristics curve analysis identified a score of 2 as the optimal cut‐off value for the prediction model (divided into 0‐1 and 2‐5). In the validation set, the sensitivity and negative predictive value for HCC occurrence were 87.5% and 99.7%, respectively, at 2 years and 71.4% and 98.0%, respectively, at 3 years.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>A prediction model combining these four factors contributes to an efficient surveillance strategy for HCC occurrence after DAA‐mediated SVR.</jats:p></jats:sec>

収録刊行物

被引用文献 (5)*注記

もっと見る

参考文献 (30)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ